The collective findings indicate that chemerin concentrations are modifiable in obesity and may contribute to human diseases that are associated with obesity and have an inflammatory component [11], [12], [25], [26]. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.